Quantcast

Latest Jazz Pharmaceuticals plc Stories

2014-12-02 16:27:36

Posters Include an Epidemiological Measure of the Effectiveness Analysis of Defibrotide from a Phase 3 Trial in Severe Hepatic VOD, as well as Updates from an International Compassionate Use Program

2014-11-04 16:28:09

Company Reports Third Quarter 2014 Total Revenues of $307 Million, Driven by Strong Sales of Xyrem, Erwinaze and Defitelio DUBLIN, Nov.

2014-08-05 16:27:58

Company Reports Second Quarter 2014 Total Revenues of $291 Million, Driven by Strong Sales of Xyrem, Erwinaze and Defitelio DUBLIN, Aug.

2014-08-05 16:27:45

Jazz Pharmaceuticals owns worldwide rights to defibrotide DUBLIN, Aug.

2014-07-22 16:27:22

DUBLIN, July 22, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 second quarter financial results on Tuesday, August 5, 2014,


Word of the Day
  • an ornament or knob in the shape of a flower
  • In architecture, a floral ornament; specifically, the large conventional flower usually placed in the center of the abacus of a Corinthian capital or classic ceiling-caisson; also, the floreated termination of a Gothic finial.
[ "The word 'fleuron' comes from French."]